List of Tables
Table 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends
Table 2. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers & Opportunity
Table 3. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
Table 4. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
Table 5. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Company (2019-2024)
Table 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors
Table 13. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2019-2024) & (USD/MT)
Table 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2025-2030) & (USD/MT)
Table 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2019-2024) & (USD/MT)
Table 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2025-2030) & (USD/MT)
Table 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Region (2019-2024) & (%)
Table 44. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Region (2025-2030) & (%)
Table 45. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Region (2019-2024) & (%)
Table 49. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Region (2025-2030) & (%)
Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume, (2025-2030) & (K MT)
Table 57. AstraZeneca Company Information
Table 58. AstraZeneca Introduction and Business Overview
Table 59. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 61. AstraZeneca Recent Development
Table 62. Boehringer Company Information
Table 63. Boehringer Introduction and Business Overview
Table 64. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 66. Boehringer Recent Development
Table 67. Eli Lilly Company Information
Table 68. Eli Lilly Introduction and Business Overview
Table 69. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 71. Eli Lilly Recent Development
Table 72. Merck Company Information
Table 73. Merck Introduction and Business Overview
Table 74. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 76. Merck Recent Development
Table 77. Mitsubishi Tanabe Pharma Company Information
Table 78. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 79. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 81. Mitsubishi Tanabe Pharma Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Introduction and Business Overview
Table 84. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 86. Novartis Recent Development
Table 87. Takeda Company Information
Table 88. Takeda Introduction and Business Overview
Table 89. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Offerings
Table 91. Takeda Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Downstream Customers
Table 95. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Picture
Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume (2019-2030) & (K MT)
Figure 5. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price (2019-2030) & (USD/MT)
Figure 6. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Report Years Considered
Figure 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue in 2023
Figure 10. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Sitagliptin Picture
Figure 12. Vildagliptin Picture
Figure 13. Saxagliptin Picture
Figure 14. Linagliptin Picture
Figure 15. Others Picture
Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2019-2030) & (USD/MT)
Figure 21. Product Picture of Hospital Pharmacies
Figure 22. Product Picture of Retail Pharmacies
Figure 23. Product Picture of Online Pharmacies
Figure 24. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2019-2030) & (USD/MT)
Figure 29. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Volume (%), (2019-2030)
Figure 41. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 47. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 49. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 59. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 61. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 62. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industrial Chain
Figure 63. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
